H|T: The Healthtech Times – Ozempic maker Novo Nordisk buys Montréal’s Inversago for $1 billion
Posted in General

H|T: The Healthtech Times – Ozempic maker Novo Nordisk buys Montréal’s Inversago for $1 billion

Plus: US Senator questions ethics of Google’s Med-PaLM 2. The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the…

Continue Reading H|T: The Healthtech Times – Ozempic maker Novo Nordisk buys Montréal’s Inversago for $1 billion
Brain
Posted in General

H|T: The Healthtech Times – How VoxNeuro takes the subjectivity out of brain health assessments

Plus: Montreal’s Inversago raises $95-million to revive failed class of weight-loss drugs. The Healthtech Times is a weekly newsletter covering healthtech news from Canada…

Continue Reading H|T: The Healthtech Times – How VoxNeuro takes the subjectivity out of brain health assessments